Hope in sight for an oral antiviral pill against COVID-19
24 Mar 2021
byElvira Manzano
The oral antiviral drug molnupiravir, given for 5 days, eliminated SARS-CoV-2 in the nasopharynx of patients with COVID-19, interim results of a phase IIa study have shown, boosting hopes for its potential use in the outpatient setting.